Archive for April, 2008

Pharmaceutical Pricing & Reimbursement Conference 2008

Thursday, April 24th, 2008

Submitted by THE HEALTH ECONOMICS BLOG
Arrowhead-Spectra Conferences announces that it is hosting an Expert Opinion Conference on Pharmaceutical Pricing and Reimbursement at the Royal Society of Medicine, in Central London, UK on the 29th May, 2008
For the program please klick here

Posted by ustaginnus@hotmail.com at 4/23/2008 0 comments

Comparative-Effectiveness Bill to Hit Senate

Wednesday, April 16th, 2008

Submitted by THE HEALTH ECONOMICS BLOG
FDAnews Drug Daily Bulletin
April 14, 2008 Vol. 5 No. 73
Comparative-Effectiveness Bill to Hit Senate
A bill establishing a comparative-effectiveness research institute is scheduled for introduction in the Senate this week, congressional staffers say.
The Comparative Effectiveness Research Act of 2008, sponsored by Sens. Kent Conrad (D-N.D.) and Max Baucus (D-Mont.), would establish […]

Gold and gold stocks were more or less unchanged for this past week. In the last two posts, I said that I was getting mixed messages from the charts I analyze, which seems to make sense now, as the bulls and bears are at about equal force.

Monday, April 14th, 2008

Submitted by BioHealth Investor Blog
was dreading this announcement, but its time has come. My career as a dentist is finally taking off and keeping me too busy to maintain this blog’s full potential.
Therefore, after a year and a half of surprising success I have no choice but to place BioHealth Investor(BHI) up for sale.
BHI is […]

Co-Payments Go Way Up for Drugs With High Prices

Monday, April 14th, 2008

Submitted by THE HEALTH ECONOMICS BLOG
The New York Times
National Desk; SECTA
Health insurance companies are rapidly adopting a new pricing system for very expensive drugs, asking patients to pay hundreds and even thousands of dollars for prescriptions for medications that may save their lives or slow the progress of serious diseases.
With the new pricing system, insurers […]

Friday’s Top Medical & Biotech Stocks

Monday, April 14th, 2008

Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
PDL BIOPHARMA INC [PDLI] +16.91%
SENESCO TECH [SNT] +10.40%
TRANSDEL PHARMACTL [TDLP.OB] +8.53%
METABASIS THERAPEUTI [MBRX] +8.14%
MICROMET INC [MITI] +7.94%
Diagnostic Substances
ORCHID CELLMARK INC [ORCH] +5.36%
PRESSURE BIOSCIENC [PBIO] +3.42%
REMOTEMDX INC [RMDX.OB] +3.25%
LEXICON PHARMACEUTCL […]

Brazil may reject patent of AIDS drug due to price

Friday, April 11th, 2008

Submitted by THE HEALTH ECONOMICS BLOG

RIO DE JANEIRO, April 10 (Reuters) - Brazil has decreed U.S. pharmaceutical firm Gilead’s AIDS drug Tenofovir “in the public interest”, signaling it may reject its patent request because of a high price and negotiate imports of generic drug.
The Health Ministry said in a decree published on Wednesday patenting the […]

To Antigenics or Not to Antigenics?

Friday, April 11th, 2008

Submitted by BioHealth Investor Blog
by Michael Shulman
BiotechBlitz
Antigenics (AGEN) got a Russian approval for its cancer immunotherapy — a cancer “vaccine” is the sexy, headline grabbing term. This also created a few seconds of buzz around two other immunotherapy companies, Dendreon (DNDN) and Cell Genesys (CEGE). I mention these two other companies because (for purposes of […]

Thursday’s Top Medical & Biotech Stocks

Friday, April 11th, 2008

Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
GENETIC TECH SPON [GENE] +18.21%
TRUBION PHARMACEUTIC [TRBN] +15.83%
XENACARE HOLDINGS [XCHO.OB] +15.38%
VION PHARMACEUTICALS [VION] +14.97%
NORTHFIELD LABS IN [NFLD] +13.86%
Diagnostic Substances
AVIGEN INC [AVGN] +14.58%
ISTA PHARMACTLS [ISTA] +9.41%
HUMAN GENOME SCI [HGSI] +8.33%
INFINITY […]

Aida Pharma Affiliate Developing New Antibiotic

Thursday, April 10th, 2008

Submitted by BioHealth Investor Blog
by Richard Daverman, PhD
ChinaBio Today
Aida Pharmaceuticals, Inc. (OTCBB: AIDA) is working on a new wide-spectrum antibiotic that was discovered by its recently acquired affiliate, the Jiangsu Institute of Microbiology Co., Ltd (JSIM). Wetimicin, which belongs to a new generation of amino-glycoside antibiotics, is in Phase I trials. Aida believes the product […]

Wednesday’s Top Medical & Biotech Stocks

Thursday, April 10th, 2008

Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
PROTEO INC [PTEO.OB] +31.19%
CHAMPIONS BIOTECHNLG [CSBR.OB] +9.52%
IOMAI CORPORATION [IOMI] +9.43%
LPATH INC [LPTN.OB] +9.03%
GENAERA CORP [GENR] +8.21%
Diagnostic Substances
ISTA PHARMACTLS [ISTA] +13.48%
TORREYPINES THERAPEU [TPTX] +6.37%
REMOTEMDX INC [RMDX.OB] +3.40%
AVALON PHARMACEUTIC [AVRX] +1.85%
AVIGEN […]

Host of pricing models proposed for UK drugs